Skip to main content
. 2022 Mar 7;22:106. doi: 10.1186/s12876-022-02132-0

Table 3.

Subgroup analysis based on study location, type of participants and population size

Subgroups No. of studies No. of patients OR and P value for mortality of different symptoms
GI symptom I 2 for GI symptom Diarrhea Nausea/vomiting Abdominal pain
1. Study location
 1.1 Asia 28 39,501 (72%) 1.43, P=0.01 54.7% 1.32, P=0.21 1.3, P=0.36 1.07, P=0.85
 Sub-subgroups for studies in Asia:
  1.1.1 GI group older than non-GI group 7 32,894 2.43, P<0.01 66.9%
  1.1.2 GI group younger than non-GI group 6 3048 1.2, P=0.29 15.8%
 1.2 America 12 8324 (15%) 0.64, P<0.01 42.7% 0.81, P=0.37 0.84, P=0.8 NA
 Sub-subgroups for studies in America:
  1.2.1 GI group older than non-GI group NA NA NA NA
  1.2.2 GI group younger than non-GI group 5 3990 0.55, P<0.01 30.6%
 1.3 Europe 10 2653 (5%) 0.4, P<0.01 77% 0.51, P=0.07 0.7, P=0.51 0.61, P=0.76
 Sub-subgroups for studies in Europe:
  1.3.1 GI group older than non-GI group NA NA NA NA
  1.3.2 GI group younger than non-GI group 3 805 0.23, P<0.01 84%
 1.4 Other 3 4767(8%) 0.92, P=0.83 87.8% 0.93, P=0.92 NA NA
2. Only include critically ill patients?
 3.1 Yes 6 1124(2%) 1.42, P=0.36 74.6% 1.3, P=0.45 0.92, P=0.71 0.75, P=0.45
 3.2 No 47 54,121 (98%) 0.83, P=0.1 78.3% 0.92, P=0.69 1.37, P=0.28 2.67, P=0.05
3. Population size
 4.1 <500 36 7436 (13%) 0.93, P=0.66 72.1% 1.05, P=0.82 1.19, P=0.51 1.04, P=0.92
 4.2 >=500 17 47,809 (87%) 0.84, P=0.25 85.7% 0.94, P=0.83 1.16, P=0.68 NA
4. Average age of GI group and non-GI group
 4.1 GI group older than non-GI group 8 33,294 (60%) 1.89, P=0.02 69%
 4.2 GI group younger than non-GI group 14 7843 (14%) 0.61, P=0.01 80%
 4.3 Unknown 31 14,058 (26%) 0.89, P=0.36 64%

OR, odds ratio; GI, gastrointestinal; NA, not available